Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII

Author(s): Aditi Redij, Simone Carradori*, Andrea Petreni, Claudiu T. Supuran and Mrunmayee P. Toraskar*

Volume 23, Issue 10, 2023

Published on: 08 March, 2023

Page: [1217 - 1223] Pages: 7

DOI: 10.2174/1871520623666230220162506

Price: $65

Abstract

Aim: Human carbonic anhydrase (CA, EC 4.2.1.1) isoforms IX and XII are validated antitumor/ antimetastatic drug and tumor imaging targets with sulfonamide inhibitors and monoclonal antibodies in clinical development. Coumarins act as isoform-selective inhibitors of these isoforms over the cytosolic and mitochondrial ones.

Methods: We report the synthesis and in vitro CA inhibitory evaluation of a large panel of coumarins incorporating pyrazole-1-carboxamide moieties. Compounds were fully characterized before the assessment of their inhibitory activity. A stopped-flow CO2 hydrase assay was performed for the biological test.

Results: These coumarins did not inhibit the widespread, off-target isoforms CA I and II (KI >50 μM), but they were sub-micromolar CA IX/XII inhibitors with an interesting selectivity index higher than the reference compound. Selectivity between α- and β-class of CAs was also promising.

Conclusion: These compounds may be used as leads for the rational design and development of non-sulfonamide CA IX/XII effective inhibitors.

Keywords: Carbonic anhydrase, hCA IX, hCA XII, antitumor, coumarin, pyrazole-1-carboxamides.

« Previous
Graphical Abstract

[1]
Aspatwar, A.; Tolvanen, M.E.E.; Barker, H.; Syrjänen, L.; Valanne, S.; Purmonen, S.; Waheed, A.; Sly, W.S.; Parkkila, S. Carbonic anhydrases in metazoan model organisms: Molecules, mechanisms, and physiology. Physiol. Rev., 2022, 102(3), 1327-1383.
[http://dx.doi.org/10.1152/physrev.00018.2021] [PMID: 35166161]
[2]
Supuran, C.T. Structure and function of carbonic anhydrases. Biochem. J., 2016, 473(14), 2023-2032.
[http://dx.doi.org/10.1042/BCJ20160115] [PMID: 27407171]
[3]
Supuran, C.T. Emerging role of carbonic anhydrase inhibitors. Clin. Sci., 2021, 135(10), 1233-1249.
[http://dx.doi.org/10.1042/CS20210040] [PMID: 34013961]
[4]
Ozensoy Guler, O.; Capasso, C.; Supuran, C.T. A magnificent enzyme superfamily: Carbonic anhydrases, their purification and characterization. J. Enzyme Inhib. Med. Chem., 2016, 31(5), 689-694.
[http://dx.doi.org/10.3109/14756366.2015.1059333] [PMID: 26118417]
[5]
Supuran, C.T. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov., 2008, 7(2), 168-181.
[http://dx.doi.org/10.1038/nrd2467] [PMID: 18167490]
[6]
Supuran, C. Carbonic anhydrases an overview. Curr. Pharm. Des., 2008, 14(7), 603-614.
[http://dx.doi.org/10.2174/138161208783877884] [PMID: 18336305]
[7]
Supuran, C.T. Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin. Drug Metab. Toxicol., 2016, 12(4), 423-431.
[http://dx.doi.org/10.1517/17425255.2016.1154534] [PMID: 26878088]
[8]
Supuran, C.T. Anti-obesity carbonic anhydrase inhibitors: Challenges and opportunities. J. Enzyme Inhib. Med. Chem., 2022, 37(1), 2478-2488.
[http://dx.doi.org/10.1080/14756366.2022.2121393] [PMID: 36073149]
[9]
Chen, R.; Liao, H.; Chen, X.; Wang, C.; Wu, H.; Zheng, Z.; Lu, J.; Lin, J.; Huang, Z.; Lin, J.; Zhong, N.; Zhang, N. Carbonic anhydrase inhibitors: A new dawn for the treatment of obstructive sleep apnea. Am. J. Respir. Crit. Care Med., 2022, 206(8), 1049-5.
[http://dx.doi.org/10.1164/rccm.202206-1209LE] [PMID: 35820074]
[10]
Nerella, S.G.; Singh, P.; Arifuddin, M.; Supuran, C.T. Anticancer carbonic anhydrase inhibitors: A patent and literature update 2018-2022. Expert Opin. Ther. Pat., 2022, 32(8), 833-847.
[http://dx.doi.org/10.1080/13543776.2022.2083502] [PMID: 35616541]
[11]
Mishra, C.B.; Tiwari, M.; Supuran, C.T. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med. Res. Rev., 2020, 40(6), 2485-2565.
[http://dx.doi.org/10.1002/med.21713] [PMID: 32691504]
[12]
Maresca, A.; Temperini, C.; Vu, H.; Pham, N.B.; Poulsen, S.A.; Scozzafava, A.; Quinn, R.J.; Supuran, C.T. Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors. J. Am. Chem. Soc., 2009, 131(8), 3057-3062.
[http://dx.doi.org/10.1021/ja809683v] [PMID: 19206230]
[13]
Maresca, A.; Temperini, C.; Pochet, L.; Masereel, B.; Scozzafava, A.; Supuran, C.T. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J. Med. Chem., 2010, 53(1), 335-344.
[http://dx.doi.org/10.1021/jm901287j] [PMID: 19911821]
[14]
Eldehna, W.M.; Taghour, M.S.; Al-Warhi, T.; Nocentini, A.; Elbadawi, M.M.; Mahdy, H.A.; Abdelrahman, M.A.; Alotaibi, O.J.; Aljaeed, N.; Elimam, D.M.; Afarinkia, K.; Abdel-Aziz, H.A.; Supuran, C.T. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms. J. Enzyme Inhib. Med. Chem., 2022, 37(1), 531-541.
[http://dx.doi.org/10.1080/14756366.2021.2024528] [PMID: 34991416]
[15]
Mohammed, A.; Supuran, C.T.; Thacker, P.S.; Tiwari, P.L.; Goud, N.S.; Srikanth, D.; Angeli, A. Synthesis and biological evaluation of coumarin carboxamides as selective and potent inhibitors of carbonic anhydrases IX and XII. Anticancer. Agents Med. Chem., 2022, 22(14), 2647-2654.
[http://dx.doi.org/10.2174/1871520622666220304184525] [PMID: 35249507]
[16]
Gumus, A.; Bozdag, M.; Akdemir, A.; Angeli, A.; Selleri, S.; Carta, F.; Supuran, C.T. Thiosemicarbazide-substituted coumarins as selective inhibitors of the tumor associated human carbonic anhydrases IX and XII. Molecules, 2022, 27(14), 4610.
[http://dx.doi.org/10.3390/molecules27144610] [PMID: 35889480]
[17]
Onyılmaz, M.; Koca, M.; Bonardi, A.; Degirmenci, M.; Supuran, C.T. Isocoumarins: A new class of selective carbonic anhydrase IX and XII inhibitors. J. Enzyme Inhib. Med. Chem., 2022, 37(1), 743-748.
[http://dx.doi.org/10.1080/14756366.2022.2041630] [PMID: 35188025]
[18]
Supuran, C.T. Coumarin carbonic anhydrase inhibitors from natural sources. J. Enzyme Inhib. Med. Chem., 2020, 35(1), 1462-1470.
[http://dx.doi.org/10.1080/14756366.2020.1788009] [PMID: 32779543]
[19]
Nocentini, A.; Angeli, A.; Carta, F.; Winum, J.Y.; Zalubovskis, R.; Carradori, S.; Capasso, C.; Donald, W.A.; Supuran, C.T. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J. Enzyme Inhib. Med. Chem., 2021, 36(1), 561-580.
[http://dx.doi.org/10.1080/14756366.2021.1882453] [PMID: 33615947]
[20]
Supuran, C.T. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin. Investig. Drugs, 2018, 27(12), 963-970.
[http://dx.doi.org/10.1080/13543784.2018.1548608] [PMID: 30426805]
[21]
Thacker, P.S.; Tiwari, P.L.; Angeli, A.; Srikanth, D.; Swain, B.; Arifuddin, M.; Supuran, C.T. Synthesis and biological evaluation of coumarin-linked 4-anilinomethyl-1,2,3-triazoles as potent inhibitors of carbonic anhydrases IX and XIII involved in tumorigenesis. Metabolites, 2021, 11(4), 225.
[http://dx.doi.org/10.3390/metabo11040225] [PMID: 33917033]
[22]
Wang, Y.; Cheng, F.X.; Yuan, X.L.; Tang, W.J.; Shi, J.B.; Liao, C.Z.; Liu, X.H. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Eur. J. Med. Chem., 2016, 112, 231-251.
[http://dx.doi.org/10.1016/j.ejmech.2016.02.009] [PMID: 26900656]
[23]
Ahmed, E.Y.; Elserwy, W.S.; El-Mansy, M.F.; Serry, A.M.; Salem, A.M.; Abdou, A.M.; Abdelrahman, B.A.; Elsayed, K.H.; Abd Elaziz, M.R. Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives. Bioorg. Med. Chem. Lett., 2021, 48128258
[http://dx.doi.org/10.1016/j.bmcl.2021.128258] [PMID: 34246754]
[24]
Liu, X.H.; Liu, H.F.; Chen, J.; Yang, Y.; Song, B.A.; Bai, L.S.; Liu, J.X.; Zhu, H.L.; Qi, X.B. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Bioorg. Med. Chem. Lett., 2010, 20(19), 5705-5708.
[http://dx.doi.org/10.1016/j.bmcl.2010.08.017] [PMID: 20800480]
[25]
Saeed, A.; Mahesar, P.A.; Channar, P.A.; Larik, F.A.; Abbas, Q.; Hassan, M.; Raza, H.; Seo, S.Y. Hybrid pharmacophoric approach in the design and synthesis of coumarin linked pyrazolinyl as urease inhibitors, kinetic mechanism and molecular docking. Chem. Biodivers., 2017, 14(8)e1700035
[http://dx.doi.org/10.1002/cbdv.201700035] [PMID: 28574649]
[26]
Patel, M.; Pandey, N.; Timaniya, J.; Parikh, P.; Chauhan, A.; Jain, N.; Patel, K. Coumarin-carbazole based functionalized pyrazolines: Synthesis, characterization, anticancer investigation and molecular docking. RSC Advances, 2021, 11(44), 27627-27644.
[http://dx.doi.org/10.1039/D1RA03970A] [PMID: 35480680]
[27]
Secci, D.; Carradori, S.; Bolasco, A.; Chimenti, P.; Yáñez, M.; Ortuso, F.; Alcaro, S. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Eur. J. Med. Chem., 2011, 46(10), 4846-4852.
[http://dx.doi.org/10.1016/j.ejmech.2011.07.017] [PMID: 21872365]
[28]
Kurt, B.Z.; Dag, A.; Doğan, B.; Durdagi, S.; Angeli, A.; Nocentini, A.; Supuran, C.T.; Sonmez, F. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Bioorg. Chem., 2019, 87, 838-850.
[http://dx.doi.org/10.1016/j.bioorg.2019.03.003] [PMID: 31003041]
[29]
Amin, K.M.; Abou-Seri, S.M.; Awadallah, F.M.; Eissa, A.A.M.; Hassan, G.S.; Abdulla, M.M. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells. Eur. J. Med. Chem., 2015, 90, 221-231.
[http://dx.doi.org/10.1016/j.ejmech.2014.11.027] [PMID: 25461322]
[30]
Khalifah, R.G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem., 1971, 246(8), 2561-2573.
[http://dx.doi.org/10.1016/S0021-9258(18)62326-9] [PMID: 4994926]
[31]
Langella, E.; D’Ambrosio, K.; D’Ascenzio, M.; Carradori, S.; Monti, S.M.; Supuran, C.T.; De Simone, G. A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases. Chemistry, 2016, 22(1), 97-100.
[http://dx.doi.org/10.1002/chem.201503748] [PMID: 26507456]
[32]
Liguori, F.; Carradori, S.; Ronca, R.; Rezzola, S.; Filiberti, S.; Carta, F.; Turati, M.; Supuran, C.T. Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: An insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells. J. Enzyme Inhib. Med. Chem., 2022, 37(1), 1857-1869.
[http://dx.doi.org/10.1080/14756366.2022.2091557] [PMID: 35768159]
[33]
Mollica, A.; Locatelli, M.; Macedonio, G.; Carradori, S.; Sobolev, A.P.; De Salvador, R.F.; Monti, S.M.; Buonanno, M.; Zengin, G.; Angeli, A.; Supuran, C.T. Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars. J. Enzyme Inhib. Med. Chem., 2016, 31(S4), 1-6.
[http://dx.doi.org/10.1080/14756366.2016.1214951]
[34]
Giovannuzzi, S.; Hewitt, C.S.; Nocentini, A.; Capasso, C.; Flaherty, D.P.; Supuran, C.T. Coumarins effectively inhibit bacterial α-carbonic anhydrases. J. Enzyme Inhib. Med. Chem., 2022, 37(1), 333-338.
[http://dx.doi.org/10.1080/14756366.2021.2012174] [PMID: 34979838]

Rights & Permissions Print Cite
Article Metrics
27
2
© 2024 Bentham Science Publishers | Privacy Policy